Judges: Seattle biotech can pursue $23M claim
Federal appeals court: Seattle biotech can pursue $23 million claim against former consultant Seattle biotechnology firm Cell Therapeutics Inc. can pursue claims for nearly $23 million against a former consultant, a federal appeals court ruled Wednesday. The ruling by a three-judge panel ...